$DSS News

DSS Q1 EPS $(0.60) Misses $(0.38) Estimate, Sales $4.331M Miss $5.100M Estimate

DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing

DSS Announces Going Concern Warning Included In 2025 Annual Report

DSS, Inc. Letter to Shareholders

DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering

DSS Commences ~$1M Offering Of 900K Common shares At $1/Share

DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering

DSS, Inc. Prices $1M Underwritten Public Offering Of 900,000 Common Shares At $1.00 Each

Reported Earlier, DSS Proposes Public Offering Of Common Stock, Proceeds To Support General Corporate And Working Capital Needs

DSS, Inc. Announces Launch of Proposed Public Offering

Do Its Financials Have Any Role To Play In Driving DS Sigma Holdings Berhad's (KLSE:DSS) Stock Up Recently?

Investors Could Be Concerned With DS Sigma Holdings Berhad's (KLSE:DSS) Returns On Capital

DSS Inc's Sweet Sense Has Received A Decision To Grant European Patent Number EP3618873 Titled "LOW GLYCEMIC SUGAR COMPOSITION (TO CONTROL BLOOD GLUCOSE LEVELS AND TREAT DIABETES AND RELATED CONDITIONS)"

Estimating The Intrinsic Value Of DS Sigma Holdings Berhad (KLSE:DSS)

Should Weakness in DS Sigma Holdings Berhad's (KLSE:DSS) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Impact BioMedical Says On July 21, 2025, Co Converted $12M Debt To Equity With DSS Through Issuance Of 31.9M Shares

DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger

DSS' Impact BioMedical Enters Into Definitive Merger Agreement With Dr. Ashleys

DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth

DSS Q1 EPS $(0.55) Up From $(0.58) YoY, Sales $4.95M Up From $3.87M YoY